The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Prestige Consumer Healthcare Inc shares valued at $898,241 were sold by Lombardi Ronald M. on Nov 19 ’24. At $82.60 per share, Lombardi Ronald M. sold 10,875 shares. The insider’s holdings dropped to 320,952 shares worth approximately $27.01 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Lombardi Ronald M. purchased 10,875 shares, netting a total of over 887,187 in proceeds.
Before that, Lombardi Ronald M. had sold 82,237 shares from its account. In a trade valued at $6,789,764, the Chief Executive Officer traded Prestige Consumer Healthcare Inc shares for $82.56 each. Upon closing the transaction, the insider’s holdings decreased to 82,237 shares, worth approximately $27.01 million.
As published in a research note from DA Davidson on June 21, 2024, Prestige Consumer Healthcare Inc [PBH] has been rated up from a Neutral to a Buy and the price target has been revised to $93 from $65. Analysts at Canaccord Genuity started covering the stock with ‘”a Buy”‘ outlook in a report released in mid November. As of May 10, 2022, Jefferies has increased its “Hold” rating to a “Buy” for PBH. Earlier on May 09, 2022, Oppenheimer upgraded its rating. Their new recommendation was “an Outperform” for PBH stock which previously was a “a Perform”.
Analyzing PBH Stock Performance
During the last five days, there has been a surge of approximately 1.81%. Over the course of the year, Prestige Consumer Healthcare Inc shares have jumped approximately 37.49%. Shares of the company reached a 52-week high of $86.36 on 11/25/24 and a 52-week low of $57.95 on 01/05/24. A 50-day SMA is recorded $74.97, while a 200-day SMA reached $70.97. Nevertheless, trading volume fell to 0.18 million shares from 0.32 million shares the previous day.
Support And Resistance Levels for Prestige Consumer Healthcare Inc (PBH)
According to the 24-hour chart, there is a support level at 83.61, which, if violated, would cause prices to drop to 83.04. In the upper region, resistance lies at 84.52. The next price resistance is at 84.86. RSI (Relative Strength Index) is 72.13 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.23, which suggests the price will increase in the coming days. Percent R is at 32.40%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
